Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
2.985
+0.050 (1.70%)
Nov 10, 2026, 4:00 PM EST - Market closed
Nasus Pharma Market Cap
Nasus Pharma has a market cap or net worth of $34.97 million as of November 10, 2026. It is the 32,623rd most valuable company in the world and the 4,828th biggest in the United States. Its market cap has decreased by 48.54% in one year.
Market Cap
34.97M
Enterprise Value
23.25M
1-Year Change
-48.54%
Global Rank
Country Rank
#4,828 United States
Category
ChartMarket Cap Chart
Since the IPO on August 14, 2025, Nasus Pharma's market cap has decreased from $72.08M to $34.97M, a decrease of -51.49%. That is a compound annual growth rate of -44.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 34.97M | -57.82% |
| Dec 31, 2025 | 82.90M | 15.01% |
| Aug 14, 2025 | 72.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 167.52B |
| Bristol-Myers Squibb Company | 127.02B |
| Sanofi | 111.86B |
| GSK plc | 101.26B |
| Biogen | 36.71B |
| Grifols | 7.48B |
| Organon & Co. | 3.64B |
| Amarin Corporation | 244.66M |